BTMD biote Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: BTMD

Price (delayed)

$1.3

Market cap

$46.71M

P/E Ratio

8.13

Dividend/share

N/A

EPS

$0.16

Enterprise value

$164.18M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 41
Highlights
biote's quick ratio has increased by 40% from the previous quarter and by 11% YoY
The equity has grown by 23% YoY but it has contracted by 17% from the previous quarter
The EPS has plunged by 84% YoY and by 67% from the previous quarter
BTMD's net income has plunged by 81% YoY and by 62% from the previous quarter
Sector: Healthcare
Industry: Medical Care Facilities
Website: https://biote.com
Peers: HERE

Key stats

What are the main financial stats of BTMD

BTMD stock price

How has the biote stock price performed over time
Intraday
-1.52%
1 week
-2.99%
1 month
-19.25%
1 year
-57.93%
YTD
-50%
QTD
-31.22%

Financial performance

How have biote's revenue and profit performed over time
Revenue
$183.53M
Gross profit
$125.86M
Operating income
$14.75M
Net income
$5.86M
Gross margin
68.6%
Net margin
3.2%
BTMD's net income has plunged by 81% YoY and by 62% from the previous quarter
BTMD's net margin has dropped by 80% year-on-year and by 61% since the previous quarter
BTMD's operating income has dropped by 58% year-on-year and by 49% since the previous quarter
The company's operating margin has shrunk by 55% YoY and by 48% QoQ

Price vs fundamentals

How does BTMD's price correlate with its fundamentals

Growth

What is biote's growth rate over time

Valuation

What is biote stock price valuation
BTMD P/E details
P/E
8.13
P/B
N/A
P/S
0.2
EV/EBIT
8.93
EV/EBITDA
7.18
EV/Sales
0.89
The EPS has plunged by 84% YoY and by 67% from the previous quarter
The P/E is 59% more than the last 4 quarters average of 5.2
The equity has grown by 23% YoY but it has contracted by 17% from the previous quarter
The stock's price to sales (P/S) is 65% less than its 5-year quarterly average of 0.6 and 48% less than its last 4 quarters average of 0.4
BTMD's revenue is down by 8% year-on-year and by 2.5% since the previous quarter

Efficiency

How efficient is biote business performance
The return on assets has dropped by 79% year-on-year and by 62% since the previous quarter
BTMD's ROIC has dropped by 65% year-on-year and by 45% since the previous quarter
The ROS has plunged by 57% YoY and by 39% from the previous quarter

Dividends

What is BTMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BTMD.

Financial health

How did biote financials performed over time
biote's total assets is 36% lower than its total liabilities
The current ratio rose by 46% YoY and by 11% QoQ
biote's quick ratio has increased by 40% from the previous quarter and by 11% YoY
BTMD's debt to equity has dropped by 54% year-on-year
The equity has grown by 23% YoY but it has contracted by 17% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.